NYSE:RDWAerospace & Defense
Redwire (NYSE:RDW) Secures Contract for Space-Based Cancer Research with Aspera Biomedicines
Redwire (NYSE:RDW) recently secured a contract from Aspera Biomedicines to utilize its Pharmaceutical In-space Laboratory for cancer research, potentially impacting its stock performance. The company saw its share price rise by 14% last month, in part reflecting broader market trends, which were up by 12% over the past year. Redwire's recent financial reports showed improved net loss figures despite a decline in sales, while new contracts, such as the delivery of an ESA Comet Interceptor...